CCDC33 antisense RNA 1 (CCDC33-AS1)

CCDC33 antisense RNA 1 is a long noncoding RNA (lncRNA), a member of non-protein-coding transcripts longer than 200 nucleotides. The biological characteristics, disease associations, and therapeutic targeting potential of CCDC33-AS1 are currently unclear and not covered in reviewed literature. It appears to be a gene-specific lncRNA designated by its genomic location (antisense to CCDC33), but there is no strong evidence that it serves as a conventional “drug target” such as an enzyme, receptor, transporter, or signaling protein[1][2][3]. The gene aliases listed are consistent with noncoding transcript nomenclature but may be redundant or non-standardized. No molecular mechanism, biomarker role, disease association, or drug interactions have been established for this lncRNA in the available scientific literature. There is no evidence that CCDC33 antisense RNA 1 is a validated therapeutic target, or that it qualifies as a classic receptor, enzyme, or regulatory disease protein. The aliases listed include some redundancy (“lnc-CYP11A1-1” is repeated; “CCDC33-AS1” is both canonical and one alias). Disease associations, drug interactions, mechanisms, biomarkers, and safety concerns are not described or supported in peer-reviewed sources.

Other names

lnc-CYP11A1-1CCDC33-AS1